FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

A Vandermeers

Research Profile

Chemicals & Drugs

Co-author Network

Publications

TOP 3
H Dahma; P Gourlet; A Vandermeers; MC Vandermeers-Piret; Patrick Robberecht
Evidence that the chromogranin B fragment 368-417 extracted from a pheochromocytoma is phosphorylated.
MC Vandermeers-Piret; A Vandermeers; P Gourlet; M H Ali; Magali Waelbroeck; Patrick Robberecht
Evidence that the lizard helospectin peptides are O-glycosylated.
V Walraevens; MC Vandermeers-Piret; A Vandermeers; P Gourlet; Patrick Robberecht
Isolation and primary structure of the CCI papain-like cysteine proteinases from the latex of Carica candamarcensis hook.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of A Vandermeers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: H Dahma; P Gourlet; A Vandermeers; MC Vandermeers-Piret; Patrick Robberecht
Evidence that the chromogranin B fragment 368-417 extracted from a pheochromocytoma is phosphorylated.
Peptides 2001;22(9):1491-9.
2000: MC Vandermeers-Piret; A Vandermeers; P Gourlet; M H Ali; Magali Waelbroeck; Patrick Robberecht
Evidence that the lizard helospectin peptides are O-glycosylated.
European journal of biochemistry / FEBS 2000;267(14):4556-60.
1999: V Walraevens; MC Vandermeers-Piret; A Vandermeers; P Gourlet; Patrick Robberecht
Isolation and primary structure of the CCI papain-like cysteine proteinases from the latex of Carica candamarcensis hook.
Biological chemistry 1999;380(4):485-8.
1998: P Gourlet; A Vandermeers; J Van Rampelbergh; Philippe De Neef; Johnny Cnudde; Magali Waelbroeck; Patrick Robberecht
Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Annals of the New York Academy of Sciences 1998;865():247-52.
1997: P Gourlet; A Vandermeers; Patrick Robberecht; M Deschodt-Lanckman
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11.
Biochemical pharmacology 1997;54(4):509-15.
1997: Françoise Van Eylen; P Gourlet; A Vandermeers; Philippe Lebrun; André Herchuelz
Phe-Met-Arg-Phe-NH2 (FMRFa)-related peptides inhibit Na/Ca exchange in pancreatic B cells.
Advances in experimental medicine and biology 1997;426():223-5.
1997: P Gourlet; A Vandermeers; Pascale Vertongen; J Rathe; Philippe De Neef; Johnny Cnudde; Magali Waelbroeck; Patrick Robberecht
Development of high affinity selective VIP1 receptor agonists.
Peptides 1997;18(10):1539-45.
1997: P Gourlet; Pascale Vertongen; A Vandermeers; MC Vandermeers-Piret; J Rathe; Philippe De Neef; Magali Waelbroeck; Patrick Robberecht
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.
Peptides 1997;18(3):403-8.
1996: P Gourlet; A Vandermeers; MC Vandermeers-Piret; Philippe De Neef; Magali Waelbroeck; Patrick Robberecht
Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors.
Biochimica et biophysica acta 1996;1314(3):267-73.
1996: P Gourlet; A Vandermeers; MC Vandermeers-Piret; P De Neef; P Robberecht
Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy.
International journal of peptide and protein research 1996;48(4):391-6.
1996: P Gourlet; J P Vilardaga; Philippe De Neef; A Vandermeers; Magali Waelbroeck; A Bollen; Patrick Robberecht
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.
European journal of biochemistry / FEBS 1996;239(2):349-55.
1996: Magali Waelbroeck; Philippe De Neef; V Domenach; MC Vandermeers-Piret; A Vandermeers
Binding of the labelled muscarinic toxin 125I-MT1 to rat brain muscarinic M1 receptors.
European journal of pharmacology 1996;305(1-3):187-92.
1996: P Gourlet; A Vandermeers; MC Vandermeers-Piret; J Rathé; Philippe De Neef; Patrick Robberecht
C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors.
Regulatory peptides 1996;62(2-3):125-30.
1996: Françoise Van Eylen; P Gourlet; A Vandermeers; Philippe Lebrun; André Herchuelz
Effects of Phe-Met-Arg-Phe-NH2 (FMRFa)-related peptides on Na-Ca exchange and ionic fluxes in rat pancreatic B cells.
Annals of the New York Academy of Sciences 1996;779():288-9.
1996: P Gourlet; J P Vilardaga; Philippe De Neef; Magali Waelbroeck; A Vandermeers; Patrick Robberecht
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Peptides 1996;17(5):825-9.
1996: P De Clercq; Inge Depoortere; M Macielag; A Vandermeers; MC Vandermeers-Piret; Theo L Peeters
Isolation, sequence, and bioactivity of chicken motilin.
Peptides 1996;17(2):203-8.
1995: P Gourlet; A Vandermeers; MC Vandermeers-Piret; J Rathé; Philippe De Neef; Patrick Robberecht
Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors.
European journal of pharmacology 1995;287(1):7-11.
1995: A Vandermeers; MC Vandermeers-Piret; J Rathé; Magali Waelbroeck; M Jolkkonen; A Oras; E Karlsson
Purification and sequence determination of a new muscarinic toxin (MT4) from the venom of the green mamba (Dendroaspis angusticeps).
Toxicon : official journal of the International Society on Toxinology 1995;33(9):1171-9.
1995: P De Clercq; A Vandermeers; Gert van Assche; R Fiasse; Inge Depoortere; MC Vandermeers-Piret; P Deprez; Theo L Peeters
Purification and amino acid sequence of human motilin isolated from a motilin containing liver metastasis.
Regulatory peptides 1995;55(1):79-84.
1995: M C Woussen-Colle; P Gourlet; A Vandermeers; MC Vandermeers-Piret; J D'Haens; Brigitte Velkeniers; Patrick Robberecht
Identification of a new chromogranin B fragment (314-365) in endocrine tumors.
Peptides 1995;16(2):231-6.
1994: Françoise Van Eylen; P Gourlet; A Vandermeers; Philippe Lebrun; André Herchuelz
Inhibition of Na/Ca exchange by Phe-Met-Arg-Phe-NH2 (FMRFa)-related peptides in intact rat pancreatic B-cells.
Molecular and cellular endocrinology 1994;106(1-2):R1-5.
1994: X Hou; A Vandermeers; P Gourlet; MC Vandermeers-Piret; Patrick Robberecht
Structural requirements for the occupancy of rat brain PACAP receptors and adenylate cyclase activation.
Neuropharmacology 1994;33(10):1189-95.
1994: M C Woussen-Colle; P Lingier; Pascale Vertongen; MC Vandermeers-Piret; A Vandermeers; Patrick Robberecht
Chromogranin A(210-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors.
Peptides 1994;15(5):869-74.
1993: Inge Depoortere; Theo L Peeters; A Vandermeers; MC Vandermeers-Piret; J Christophe; G Vantrappen
Purification and amino acid sequence of motilin from cat small intestine.
Regulatory peptides 1993;49(1):25-32.
1992: A Vandermeers; S Vandenborre; X Hou; Philippe De Neef; Patrick Robberecht; MC Vandermeers-Piret; J Christophe
Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
European journal of biochemistry / FEBS 1992;208(3):815-9.
1992: Patrick Robberecht; P Gourlet; Philippe De Neef; M C Woussen-Colle; MC Vandermeers-Piret; A Vandermeers; J Christophe
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
Molecular pharmacology 1992;42(2):347-55.
1992: Patrick Robberecht; P Gourlet; Philippe De Neef; M C Woussen-Colle; MC Vandermeers-Piret; A Vandermeers; J Christophe
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
European journal of biochemistry / FEBS 1992;207(1):239-46.
1992: Michal Svoboda; E Ciccarelli; MC Vandermeers-Piret; A M Nagy; C Van de Weerdt; A Bollen; A Vandermeers; J Christophe
Purification, primary structure and molecular cloning of a rat ribosomal protein showing homology with yeast ribosomal protein YL34.
European journal of biochemistry / FEBS 1992;203(3):341-6.
1991: A Cauvin; Patrick Robberecht; Philippe De Neef; P Gourlet; A Vandermeers; MC Vandermeers-Piret; J Christophe
Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord.
Regulatory peptides 1991;35(2):161-73.
1991: Patrick Robberecht; M C Woussen-Colle; Philippe De Neef; P Gourlet; L Buscail; A Vandermeers; MC Vandermeers-Piret; J Christophe
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes.
FEBS letters 1991;286(1-2):133-6.
1991: P Gourlet; Philippe De Neef; M C Woussen-Colle; A Vandermeers; MC Vandermeers-Piret; Patrick Robberecht; J Christophe
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Biochimica et biophysica acta 1991;1066(2):245-51.
1991: A Vandermeers; MC Vandermeers-Piret; L Vigneron; J Rathe; M Stievenart; J Christophe
Differences in primary structure among five phospholipases A2 from Heloderma suspectum.
European journal of biochemistry / FEBS 1991;196(3):537-44.
1991: Y Bounjoua; A Vandermeers; Patrick Robberecht; MC Vandermeers-Piret; J Christophe
Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide and secretin from the ovine small intestine.
Regulatory peptides 1991;32(2):169-79.
1991: P Gourlet; M C Woussen-Colle; Patrick Robberecht; Philippe De Neef; A Cauvin; MC Vandermeers-Piret; A Vandermeers; J Christophe
Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
European journal of biochemistry / FEBS 1991;195(2):535-41.
1990: A Cauvin; MC Vandermeers-Piret; A Vandermeers; E Coussaert; Philippe De Neef; Patrick Robberecht; J Christophe
Rat PHI, PHI-GLY and PHV (1-42) stimulate adenylate cyclase in six rat tissue and cell membranes.
Peptides 1990;11(5):1009-14.
1990: L Buscail; A Cauvin; P Gourlet; D Gossen; Philippe De Neef; J Rathé; Patrick Robberecht; MC Vandermeers-Piret; A Vandermeers; J Christophe
Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide (1-27) and secretin from the small intestine of guinea pig.
Biochimica et biophysica acta 1990;1038(3):355-9.
1990: D Gossen; L Buscail; A Cauvin; P Gourlet; Philippe De Neef; J Rathe; Patrick Robberecht; MC Vandermeers-Piret; A Vandermeers; J Christophe
Amino acid sequence of VIP, PHI and secretin from the rabbit small intestine.
Peptides 1990;11(1):123-8.
1989: F Gomez; A Vandermeers; MC Vandermeers-Piret; R Herzog; J Rathe; M Stievenart; J Winand; J Christophe
Purification and characterization of five variants of phospholipase A2 and complete primary structure of the main phospholipase A2 variant in Heloderma suspectum (Gila monster) venom.
European journal of biochemistry / FEBS 1989;186(1-2):23-33.
1989: A Cauvin; A Vandermeers; MC Vandermeers-Piret; Patrick Robberecht; J Christophe
Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42).
Endocrinology 1989;125(5):2645-55.
1989: A Cauvin; A Vandermeers; MC Vandermeers-Piret; J Rathe; Patrick Robberecht; J Christophe
Peptide histidine isoleucinamide (PHI)-(1-27)-Gly as a new major form of PHI in the rat small intestine.
Endocrinology 1989;125(3):1296-302.
1989: J Abello; C Damien; Patrick Robberecht; R Hooghe; A Vandermeers; MC Vandermeers-Piret; J Christophe
Homologous and heterologous regulation of the helodermin/vasoactive-intestinal-peptide response in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
European journal of biochemistry / FEBS 1989;183(2):269-74.
1989: D Gossen; A Vandermeers; MC Vandermeers-Piret; J Rathé; A Cauvin; Patrick Robberecht; J Christophe
Isolation and primary structure of rat secretin.
Biochemical and biophysical research communications 1989;160(2):862-7.
1988: Patrick Robberecht; A Vandermeers; MC Vandermeers-Piret; P Gourlet; A Cauvin; Philippe De Neef; J Christophe
Helodermin-like peptides.
Annals of the New York Academy of Sciences 1988;527():186-203.
1987: A Vandermeers; P Gourlet; MC Vandermeers-Piret; A Cauvin; Philippe De Neef; J Rathe; Michal Svoboda; Patrick Robberecht; J Christophe
Chemical, immunological and biological properties of peptides like vasoactive-intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum).
European journal of biochemistry / FEBS 1987;164(2):321-7.
1986: J P Dehaye; J Winand; C Damien; F Gomez; P Poloczek; Patrick Robberecht; A Vandermeers; MC Vandermeers-Piret; M Stiévenart; J Christophe
Receptors involved in helodermin action on rat pancreatic acini.
The American journal of physiology 1986;251(5 Pt 1):G602-10.
1986: P Robberecht; N Yanaihara; C Yanaihara; P De Neef; J C Camus; A Vandermeers; MC Vandermeers-Piret; J Christophe
Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptors.
Peptides 1986;7 Suppl 1():79-82.
1986: J Christophe; Michal Svoboda; M Lambert; M Waelbroeck; J Winand; J P Dehaye; MC Vandermeers-Piret; A Vandermeers; P Robberecht
Effector mechanisms of peptides of the VIP family.
Peptides 1986;7 Suppl 1():101-7.
1985: P Robberecht; P De Neef; A Vandermeers; MC Vandermeers-Piret; M Svoboda; Sylvain Meuris; J De Graef; M C Woussen-Colle; C Yanaihara; N Yanaihara
Presence of helodermin-like peptides of the VIP-secretin family in mammalian salivary glands and saliva.
FEBS letters 1985;190(1):142-6.
1985: P Robberecht; J De Graef; M C Woussen; MC Vandermeers-Piret; A Vandermeers; Philippe De Neef; A Cauvin; C Yanaihara; N Yanaihara; J Christophe
Immunoreactive helodermin-like peptides in rat: a new class of mammalian neuropeptides related to secretin and VIP.
Biochemical and biophysical research communications 1985;130(1):333-42.
1984: M Hoshino; C Yanaihara; Y M Hong; S Kishida; Y Katsumaru; A Vandermeers; MC Vandermeers-Piret; P Robberecht; J Christophe; N Yanaihara
Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom.
FEBS letters 1984;178(2):233-9.
1984: J P Dehaye; J Winand; P Michel; P Poloczek; C Damien; MC Vandermeers-Piret; A Vandermeers; J Christophe
Phospholipase A2 activity of pancreatic secretory factor, a new secretagogue isolated from the venom of Heloderma suspectum.
FEBS letters 1984;172(2):284-8.
1984: P Robberecht; M Waelbroeck; P de Neef; J C Camus; A Vandermeers; MC Vandermeers-Piret; J Christophe
Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes.
FEBS letters 1984;172(1):55-8.
1984: A Vandermeers; MC Vandermeers-Piret; J Rathe; J P Dehaye; J Winand; J Christophe
Phosphorylation of 3 particulate proteins in rat pancreatic acini in response to vasoactive intestinal peptide (VIP), secretin and cholecystokinin (CCK-8).
Peptides 1984;5(2):359-65.
1984: A Vandermeers; MC Vandermeers-Piret; P Robberecht; M Waelbroeck; J P Dehaye; J Winand; J Christophe
Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom.
FEBS letters 1984;166(2):273-6.
1984: P Robberecht; M Waelbroeck; J P Dehaye; J Winand; A Vandermeers; MC Vandermeers-Piret; J Christophe
Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties.
FEBS letters 1984;166(2):277-82.
1984: J P Dehaye; J Winand; P Michel; P Robberecht; M Waelbroeck; A Vandermeers; MC Vandermeers-Piret; J Christophe
Pancreatic secretory factor (PSF), a protein from Gila monster venom stimulating enzyme secretion from rat pancreatic acini.
FEBS letters 1984;166(2):283-7.
1983: F Malaisse-Lagae; J P Dehaye; J Winand; A Vandermeers; W J Malaisse
Exocrine pancreas: difference in the amylase content of the dorsal and ventral regions.
Experientia 1983;39(9):1045-6.
1983: A Vandermeers; MC Vandermeers-Piret; J Rathe; J Christophe
Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
The Biochemical journal 1983;211(2):341-7.
1982: A Vandermeers; MC Vandermeers-Piret; A Hepburn; J Rathe; J Christophe
Evidence for the existence of actomyosin ATPase in the rat pancreas. Isolation and biochemical characterization.
European journal of biochemistry / FEBS 1982;121(2):295-9.
1980: P Thiry; A Vandermeers; MC Vandermeers-Piret; J Rathe; J Christophe
The activation of brain adenylate cyclase and brain cyclic-nucleotide phosphodiesterase by seven calmodulin derivatives.
European journal of biochemistry / FEBS 1980;103(2):409-14.